• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Aplysia Study Reveals KIBRA Binding to PKM Does Not Ensure Stabilization

by
November 19, 2026
in Biology
Reading Time: 6 mins read
0
Aplysia Study Reveals KIBRA Binding to PKM Does Not Ensure Stabilization

Aplysia Study Reveals KIBRA Binding to PKM Does Not Ensure Stabilization

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a newly published investigation in Molecular Brain, neuroscientists investigating the persistence of memory have revealed that physical association between the memory-associated kinase PKM and its scaffold KIBRA does not ensure protein stabilization. Protein kinase M is an autonomously active, truncated catalytic fragment of protein kinase C required for long-term memory maintenance across animal models. The adaptor protein KIBRA stabilizes specific PKM variants, protecting them from degradation. Using living neuronal cultures, the authors showed that several engineered and natural KIBRA mutants bound atypical PKM Apl III in bimolecular complementation tests yet failed to stabilize the enzyme.

In Aplysia sensory-motor neuron cultures, synaptic strength can be sustained for days following chemical or electrical stimulation. Repeated serotonin applications induce non-associative long-term facilitation, modeling sensitization memory, while pairing sensory neuronal firing with serotonin induces associative facilitation. Both forms of facilitation depend on PKMs generated through calpain cleavage of classical and atypical protein kinase C isoforms, termed PKM Apl I and PKM Apl III respectively. Pharmacological blockers or dominant-negative PKM constructs erase established facilitation when applied days after induction, mirroring findings in vertebrate systems. Because PKM Apl I and PKM Apl III perform distinct functions during memory maintenance, understanding how these enzymes avoid degradation within active synapses remains critical for deciphering synaptic longevity.

Previous research demonstrated that KIBRA serves as an isoform-selective stabilizer in Aplysia neurons, preserving atypical PKM Apl III but not classical PKM Apl I. Mutating three conserved residues in the proposed atypical PKM binding domain—arginine 1317, serine 1319, and arginine 1321 converted to alanines in KIBRARSR-AAA—prevents stabilization of PKM Apl III and erases long-term facilitation. Surprisingly, KIBRARSR-AAA gains the ability to stabilize classical PKM Apl I. An endogenous alternative splicing event creates a similar functional switch: KIBRAsplice contains a seven-amino-acid insertion that stabilizes PKM Apl I while failing to stabilize PKM Apl III. Human genetic studies have linked KIBRA polymorphisms to cognitive performance, while mammalian paralogs WWC2 and WWC3 participate in synaptic regulation, Hippo signaling, and cell polarity. These observations raised the question of whether failure to stabilize a kinase stems from an inability to bind, or whether association can occur without providing metabolic stability.

To evaluate interactions directly in cellular conditions, the authors harvested pleuropedal ganglia from adult hermaphrodite Aplysia californica weighing 60 to 100 grams. Ganglia were digested at 19 degrees Celsius in supplemented Leibovitz L-15 medium with Dispase II for 18 to 19 hours, under protocols approved by the Montreal Neurologic Institute animal committee. Sensory neurons dissected from pleural ganglia were cultured at 19 degrees Celsius in equal volumes of hemolymph and L-15 medium on poly-L-lysine-coated glass dishes. Expression constructs in pNEX3 plasmids were microinjected into sensory neuron nuclei with glass micropipettes using fast green dye. Cells were incubated for 24 hours to ensure recombinant expression before imaging. To avoid interference from dense pigment granules in the soma, quantitative optical measurements were performed within intermediate-thickness neurite processes. A blinded observer analyzed one region of interest per neuron, subtracting local background fluorescence.

Bimolecular fluorescence complementation, or BIFC, enabled researchers to test physical association between KIBRA variants and PKM Apl III inside living sensory neurites. Plasmids encoding an N-terminal fragment of mVenus (residues 1 to 154) and a C-terminal fragment (residues 155 to 239) were fused to KIBRA variants or PKM, alongside an enhanced cyan fluorescent protein control. Epifluorescence imaging revealed robust yellow fluorescence reconstitution between wild-type KIBRA and PKM Apl III compared to homomeric controls. When testing KIBRARSR-AAA and KIBRAsplice—both unable to stabilize PKM Apl III—the team observed robust BIFC signals matching wild-type KIBRA across multiple independent experiments. Anti-KIBRA antibody staining confirmed comparable expression levels among KIBRA variants. Non-parametric Kruskal-Wallis tests and Dunn’s multiple comparisons verified that complementation was statistically significant, demonstrating that physical proximity and fluorophore reconstitution occur despite complete loss of kinase stabilization.

The authors expanded their inquiry by modeling mutations identified in human WWC3 linked to neurodevelopmental disorders or cancer. They engineered orthologous alterations into Aplysia KIBRA: KIBRAR-Q, replacing arginine 1312 with glutamine; KIBRAR-H, replacing arginine 1341 with histidine; and KIBRAstop, introducing a stop codon at residue 1312. In KIBRA, residue 1312 resides within the conserved basic affinity arm preceding the phosphorylatable serine, whereas residue 1341 lies at the start of an alpha helix contributing to coiled-coil domains with KIBRA’s N-terminus. Fusion constructs tagged with enhanced cyan fluorescent protein were microinjected with monomeric red fluorescent protein-tagged PKMs and yellow fluorescent protein normalizers. In sensory neurites, wild-type KIBRA, KIBRAR-Q, and KIBRAR-H all elevated PKM Apl III levels compared to cyan fluorescent protein controls, although KIBRAR-H showed borderline statistical significance. These results demonstrated that point alterations in the affinity arm did not eliminate stabilization of atypical PKM.

Most surprisingly, KIBRAstop—which completely deletes the proposed atypical PKM binding site and downstream coiled-coil alpha helices—still significantly stabilized PKM Apl III. Because KIBRAstop terminates before the alternative splice junction, the same truncated construct was tested against PKM Apl I in the KIBRAsplice background. Here, KIBRAsplice, KIBRAspliceR-H, and KIBRAstop all stabilized PKM Apl I, whereas KIBRAspliceR-Q failed to do so. In both assays, KIBRAstop expressed at significantly lower levels than full-length variants, likely reflecting impaired coiled-coil formation and diminished protein stability. Despite its truncated architecture and reduced expression, KIBRAstop produced statistically significant BIFC signals with PKM Apl III. Similarly, KIBRAR-Q and KIBRAR-H exhibited strong BIFC interactions. These findings challenged the concept that kinase stabilization requires the intact canonical binding sequence, demonstrating that KIBRA maintains association and stabilizes distinct PKM isoforms through mechanisms outside the previously defined atypical binding region.

To gain structural insights into these observations, the researchers conducted AlphaFold 3 simulations on the AlphaFold Server. All models incorporated ATP and two magnesium ions, running queries five times to produce 25 models per condition. Structural outputs were analyzed with MolProbity to assess atomic clashes and Ramachandran scores, alongside interchain Predicted Alignment Error, or iPAE. The modeling revealed that KIBRA possesses multiple substrate-like peptides directly upstream of the canonical atypical PKC binding site. Although predicted to be intrinsically disordered in KIBRA alone, these peptides fit into the catalytic substrate cleft of PKM. The canonical SP3 interaction mirrored crystal structures of atypical PKC iota bound to PAR3 peptides, featuring an N-terminal affinity arm and an inhibitory C-terminal arm.

The discovery of alternative substrate peptides provided a structural explanation for why KIBRARSR-AAA and KIBRAstop maintain association with PKM. In wild-type models with PKM Apl III, SP3 exhibited the lowest iPAE values, indicating high predicted interaction stability. However, when the RSR sequence was mutated to alanines in KIBRARSR-AAA, or when SP3 was removed in KIBRAstop, predicted interactions shifted toward SP1 and SP2. In KIBRAstop simulations, SP1 and SP2 docked into the kinase pocket with low iPAE and low MolProbity clash scores (as low as 0.112 angstroms with PKM Apl III and 0.063 angstroms with PKM Apl I), utilizing conserved affinity arm motifs (IxR and LxR). MolProbity analysis also showed that KIBRARSR-AAA produced higher clashes with PKM Apl III but lower clashes with PKM Apl I, paralleling the functional stabilization switch. These findings indicate that alternative substrate peptides can substitute for SP3, preserving physical binding and complementation.

AlphaFold 3 also elucidated how alternative splicing and structural elements outside the catalytic groove modulate kinase interactions. Following the substrate peptides, KIBRA contains four conserved alpha helices, including one displaying a positively charged face. In wild-type KIBRA, this positive face is predicted to form salt bridges with acidic residues in PKM Apl III. In KIBRAsplice, insertion of seven residues repositions two glutamic acid residues onto this positive face, reducing contacts with PKM Apl III and increasing alignment error. In contrast, PKM Apl I contains a distinctive handle region absent in PKM Apl III. In KIBRAWT models with PKM Apl I, the handle frequently binds the substrate peptide in an alternate orientation. Splicing reduces this alternate handle binding, allowing canonical substrate engagement and lowering SP3 alignment error, which correlates with increased PKM Apl I stabilization by KIBRAsplice.

To reconcile the discrepancy between BIFC and stabilization, the authors proposed that BIFC captures transient, non-protective associations, whereas cellular stabilization requires stable kinase inhibition. In BIFC assays, even temporary docking can trigger irreversible fluorophore reconstitution, generating strong fluorescent signals without reflecting whether the complex persists long-term. Conversely, kinase stabilization requires continuous association: when PKMs dissociate from KIBRA, unshielded kinases are susceptible to rapid degradation. The study notes several limitations: experiments relied on plasmid overexpression in isolated neurons, which could alter stoichiometric interactions compared to physiological complexes containing binding partners like PICK1 or RSK, and AlphaFold 3 models provide static predictions rather than dynamic phosphorylation kinetics. Understanding how this inhibitory scaffold transitions into an active kinase complex during memory retrieval remains an open question for future neurobiological research.

Subject of Research: Isoform-specific PKM and KIBRA interactions in neuronal memory maintenance

Article Title: Generating models for isoform-specific PKM-KIBRA interactions with BIFC, stabilization and AlphaFold 3

Article References: Amoah, E., Dunn, T. W., Ferguson, L., Betriu Diaz, K., O’Donnell, C., Kremerskoten, J., & Sossin, W. S. (2026). Generating models for isoform-specific PKM-KIBRA interactions with BIFC, stabilization and AlphaFold 3. Molecular Brain, 19(1), Article 48. https://doi.org/10.1186/s13041-026-01321-2

Image Credits: AI Generated

DOI: 10.1186/s13041-026-01321-2

Keywords: Protein Kinase M, KIBRA, Aplysia californica, AlphaFold 3, Bimolecular Fluorescence Complementation, PKM Apl III, PKM Apl I, Synaptic Plasticity, Long-Term Facilitation, Protein Kinase C, Protein Stabilization, Alternative Splicing, Substrate Peptides, Kinase Inhibition, WWC3, Sensory Neurons, Molecular Modeling

News Source: Drew Townsend. (November 19, 2026). Aplysia Study Reveals KIBRA Binding to PKM Does Not Ensure Stabilization. Scienmag.

Tags: AlphaFold 3alternative splicingAplysia californicaBimolecular fluorescence complementationKIBRAkinase inhibitionLong-Term FacilitationMolecular modelingPKM Apl IPKM Apl IIIprotein kinase CProtein Kinase Mprotein stabilizationsensory neuronsSubstrate Peptidessynaptic plasticityWWC3
Share12Tweet7Share2ShareShareShare1

Related Posts

Skin Morphology and Gene Networks Drive Heat Tolerance in Lufeng Cattle

Skin Morphology and Gene Networks Drive Heat Tolerance in Lufeng Cattle

November 19, 2026
Plant MicroRNA Coordinates Auxin Perception and Diverse Environmental Stress Responses

Plant MicroRNA Coordinates Auxin Perception and Diverse Environmental Stress Responses

November 19, 2026

Computational Analysis Links Bacillus subtilis Iturin A to Caspases in Cervical Cancer

November 19, 2026

Indigenous Language Loss Threatens Unique Ecological Knowledge and Conservation Capacity

November 19, 2026

POPULAR NEWS

  • Anlotinib Combined with Cranial Radiotherapy Shows Promise for Lung Cancer Brain Metastases

    Anlotinib Combined with Cranial Radiotherapy Shows Promise for Lung Cancer Brain Metastases

    29 shares
    Share 12 Tweet 7
  • Curcumin Reduces Liver Steatosis in Rats by Altering Gut Microbiota and Epigenetics

    29 shares
    Share 12 Tweet 7
  • Air Sampling in Bat Caves Captures Mammalian Viruses Across Optimized Volumes

    29 shares
    Share 12 Tweet 7
  • Rimegepant Provides Meaningful Relief as Second- or Third-Line Acute Migraine Therapy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Jiangsu Sports Facility Study Identifies Economic Spillovers and Regional Siphon Effects

Adjunctive Breathing Exercises Modestly Improve Certain Childhood Asthma Lung Measures, Review Finds

Quran Recitation Linked to Reduced Labor Pain and Blood Pressure in Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.